Cart
sales@molnova.com
Danofloxacin mesylate
CAS No. 119478-55-6
Danofloxacin mesylate( CP 76,136-27 )
Catalog No. M10686 CAS No. 119478-55-6
Danofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 181 | In Stock |
|
| 50MG | 314 | In Stock |
|
| 100MG | 467 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDanofloxacin mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDanofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase.
-
DescriptionDanofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase, which is necessary for supercoiling of DNA to provide a suitable spatial arrangement of DNA within the bacterial cell.
-
In Vitro——
-
In Vivo——
-
SynonymsCP 76,136-27
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA-gyrase
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number119478-55-6
-
Formula Weight453.48
-
Molecular FormulaC19H20FN3O3·CH4O3S
-
Purity>98% (HPLC)
-
SolubilityWater: 91 mg/mL (200.67 mM)
-
SMILESCN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F.CS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Giles CJ, et al. J Vet Pharmacol Ther, 1991, 14(4), 400-410.
molnova catalog
related products
-
Elinafide
Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.
-
Isoindigotin
isoindigotin is used to treat Y.
-
Hydroxyurea
Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
